| pubmed-article:15369383 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15369383 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
| pubmed-article:15369383 | lifeskim:mentions | umls-concept:C2266856 | lld:lifeskim |
| pubmed-article:15369383 | lifeskim:mentions | umls-concept:C0456387 | lld:lifeskim |
| pubmed-article:15369383 | lifeskim:mentions | umls-concept:C1550548 | lld:lifeskim |
| pubmed-article:15369383 | lifeskim:mentions | umls-concept:C1555714 | lld:lifeskim |
| pubmed-article:15369383 | lifeskim:mentions | umls-concept:C1707689 | lld:lifeskim |
| pubmed-article:15369383 | lifeskim:mentions | umls-concept:C1705654 | lld:lifeskim |
| pubmed-article:15369383 | pubmed:issue | 20 | lld:pubmed |
| pubmed-article:15369383 | pubmed:dateCreated | 2004-9-16 | lld:pubmed |
| pubmed-article:15369383 | pubmed:abstractText | Proteasome inhibition is a therapeutic concept of current interest in anticancer research. We report here the design, synthesis, and biological characterization of prototypes of a new class of noncovalent proteasome inhibitors showing high activity in biochemical and cellular assays. | lld:pubmed |
| pubmed-article:15369383 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15369383 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15369383 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15369383 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15369383 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15369383 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15369383 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15369383 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15369383 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15369383 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15369383 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:15369383 | pubmed:issn | 0022-2623 | lld:pubmed |
| pubmed-article:15369383 | pubmed:author | pubmed-author:FuretPascalP | lld:pubmed |
| pubmed-article:15369383 | pubmed:author | pubmed-author:ImbachPatrici... | lld:pubmed |
| pubmed-article:15369383 | pubmed:author | pubmed-author:FuerstPeterP | lld:pubmed |
| pubmed-article:15369383 | pubmed:author | pubmed-author:LangMarcM | lld:pubmed |
| pubmed-article:15369383 | pubmed:author | pubmed-author:NooraniMariaM | lld:pubmed |
| pubmed-article:15369383 | pubmed:author | pubmed-author:ZimmermannJoh... | lld:pubmed |
| pubmed-article:15369383 | pubmed:author | pubmed-author:García-Echeve... | lld:pubmed |
| pubmed-article:15369383 | pubmed:author | pubmed-author:KoepplerJuerg... | lld:pubmed |
| pubmed-article:15369383 | pubmed:author | pubmed-author:LaumenKurtK | lld:pubmed |
| pubmed-article:15369383 | pubmed:author | pubmed-author:GuagnanoVitoV | lld:pubmed |
| pubmed-article:15369383 | pubmed:author | pubmed-author:RoeselJohanne... | lld:pubmed |
| pubmed-article:15369383 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15369383 | pubmed:day | 23 | lld:pubmed |
| pubmed-article:15369383 | pubmed:volume | 47 | lld:pubmed |
| pubmed-article:15369383 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15369383 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15369383 | pubmed:pagination | 4810-3 | lld:pubmed |
| pubmed-article:15369383 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15369383 | pubmed:meshHeading | pubmed-meshheading:15369383... | lld:pubmed |
| pubmed-article:15369383 | pubmed:meshHeading | pubmed-meshheading:15369383... | lld:pubmed |
| pubmed-article:15369383 | pubmed:meshHeading | pubmed-meshheading:15369383... | lld:pubmed |
| pubmed-article:15369383 | pubmed:meshHeading | pubmed-meshheading:15369383... | lld:pubmed |
| pubmed-article:15369383 | pubmed:meshHeading | pubmed-meshheading:15369383... | lld:pubmed |
| pubmed-article:15369383 | pubmed:meshHeading | pubmed-meshheading:15369383... | lld:pubmed |
| pubmed-article:15369383 | pubmed:meshHeading | pubmed-meshheading:15369383... | lld:pubmed |
| pubmed-article:15369383 | pubmed:meshHeading | pubmed-meshheading:15369383... | lld:pubmed |
| pubmed-article:15369383 | pubmed:meshHeading | pubmed-meshheading:15369383... | lld:pubmed |
| pubmed-article:15369383 | pubmed:meshHeading | pubmed-meshheading:15369383... | lld:pubmed |
| pubmed-article:15369383 | pubmed:meshHeading | pubmed-meshheading:15369383... | lld:pubmed |
| pubmed-article:15369383 | pubmed:meshHeading | pubmed-meshheading:15369383... | lld:pubmed |
| pubmed-article:15369383 | pubmed:meshHeading | pubmed-meshheading:15369383... | lld:pubmed |
| pubmed-article:15369383 | pubmed:meshHeading | pubmed-meshheading:15369383... | lld:pubmed |
| pubmed-article:15369383 | pubmed:meshHeading | pubmed-meshheading:15369383... | lld:pubmed |
| pubmed-article:15369383 | pubmed:meshHeading | pubmed-meshheading:15369383... | lld:pubmed |
| pubmed-article:15369383 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15369383 | pubmed:articleTitle | Entry into a new class of potent proteasome inhibitors having high antiproliferative activity by structure-based design. | lld:pubmed |
| pubmed-article:15369383 | pubmed:affiliation | Novartis Pharma AG, Novartis Institutes for Biomedical Research, CH-4002 Basel, Switzerland. | lld:pubmed |
| pubmed-article:15369383 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:15369383 | lld:chembl |
